Literature DB >> 8523571

Relationship between tumor necrosis factor alpha and feline immunodeficiency virus expressions.

L A Kraus1, W G Bradley, R W Engelman, K M Brown, R A Good, N K Day.   

Abstract

The presence of feline immunodeficiency virus (FIV) proviral DNA, expression of FIV p26 core protein, and production of tumor necrosis factor alpha (TNF-alpha) were assessed in sequential biopsies of spleen and lymph node sections, of mononuclear cells of the peripheral blood, and of the serum of specific-pathogen-free cats during the acute phase of FIV infection. A temporal relationship between TNF-alpha production and FIV p26 expression was noted. Two months following FIV infection, and preceding the detection of FIV viremia, levels of TNF-alpha in serum increased significantly (P = 0.04), and they remained elevated during FIV viremia in the third month postinfection. Immunoprecipitates representing expression of TNF-alpha and of FIV p26 were localized in common foci of lymph nodes of FIV-infected cats during this period of active viremia. With the advent of anti-FIV antibodies, circulating levels of TNF-alpha and p26 antigen and expression of TNF-alpha and p26 in the lymph nodes decreased during the fifth month postinfection, and p26 production became undetectable. With clearance of viremia, burden of proviral DNA in peripheral blood mononuclear cells became reduced (P = 0.041), with provirus remaining integrated principally within lymph nodes (P = 0.046). During aviremia, p26 expression was undetectable in any tissue but remained inducible in vitro. During acute FIV infection, TNF-alpha production and p26 expression are intimately linked.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523571      PMCID: PMC189845     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Primary HIV infection: host responses and intervention strategies.

Authors:  B Tindall; D A Cooper
Journal:  AIDS       Date:  1991-01       Impact factor: 4.177

2.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections.

Authors:  J E Barlough; C D Ackley; J W George; N Levy; R Acevedo; P F Moore; B A Rideout; M D Cooper; N C Pedersen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

4.  HIV isolation from pulmonary cells derived from bronchoalveolar lavage.

Authors:  A A Jeffrey; D Israël-Biet; J M Andrieu; P Even; A Venet
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

Review 5.  The role of tumour necrosis factor-alpha in acquired immunodeficiency syndrome.

Authors:  M Odeh
Journal:  J Intern Med       Date:  1990-12       Impact factor: 8.989

Review 6.  The effect of cytokines and pharmacologic agents on chronic HIV infection.

Authors:  G Poli; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

7.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

8.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Authors:  E S Daar; T Moudgil; R D Meyer; D D Ho
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

9.  Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats.

Authors:  S Dandekar; A M Beebe; J Barlough; T Phillips; J Elder; M Torten; N Pedersen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.

Authors:  E E Sparger; B L Shacklett; L Renshaw-Gegg; P A Barry; N C Pedersen; J H Elder; P A Luciw
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

View more
  1 in total

1.  The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression.

Authors:  E Holznagel; R Hofmann-Lehmann; C M Leutenegger; K Allenspach; S Huettner; U Forster; E Niederer; H Joller; B J Willett; U Hummel; G L Rossi; J Schüpbach; H Lutz
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.